Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: Ease - folllow-up to yesterday`s post

RE: Ease - folllow-up to yesterday`s post

posted on Apr 18, 2006 09:49AM
``The second dividend was to be from proceeds from the Fujitsu & Casio deals. If those two totaled only $15 mil - do you think Pohl would give away the entire amount in the form of a dividend``

Badgerbooster...I agree. Based on the Fujitsu PR, my take..IMHO....is that the Fujitsu settlement by itself funded the second dividend payment. I believe this because the PR was released before the Casio PR. Of course we won`t know for sure until #`s are released...but this is the way I read it based on excerpt below. GLTA

Carlsbad, Calif. - April 5, 2006 - Patriot Scientific Corporation (OTC Bulletin Board: PTSC.OB) today announced that it has received its share of the distribution of proceeds from a licensing payment made by Fujitsu Limited - announced last month as the latest global system manufacturer to purchase a license to use intellectual property protected by the Moore Microprocessor Patentâ„¢ (MMP) Portfolio. The amount will be used to fund Patriot Scientific`s second shareholder dividend of 2006, which will be issued on April 24 to shareholders of record as of March 31, 2006.

Share
New Message
Please login to post a reply